In this study, we aimed at establishing a procedure for normalizing mass spectra to improve ion distribution images, i.e., sharply defined tissue edges and increased dynamic range, acquired by mass spectrometric imaging (MSI). A crucial problem in MSI is that variations in ionization e$ciencies are observed among spectra, which arises from the heterogeneous matrix-analyte crystallization and sublimation during measurement. Such variation could generate incorrect analyte distribution images. For solving this problem, we performed spectrum normalization using an external standard (ES) compound spiked in the matrix solution. We selected methylcarbamyl platelet-activating factor (C-PAF) (C-16) as the ES compound by considering the following two criteria: (1) no other mass peaks overlap the peak of the ES compound, and (2) the ES compound has su$cient ionization capability on the tissue section, in which numerous biological compounds compete to ionize. For evaluating the optimal concentration of C-PAF, we analyzed ion images of coronal mouse brain sections by MSI using matrix solutions containing di#erent concentrations of C-PAF (0, 0.5, 5, 25, and 50 mg/mL). As a result, we found that the optimal concentration of C-PAF for normalization is 50 mg/mL. Employing the procedure, we show improved ion images of phosphatidylcholine (PC) molecular species in the mouse brain section.
Introduction
Mass spectrometric imaging (MSI) is a mass spectrometry-based imaging technique that provides distribution information regarding various biomolecules, including proteins, 1) lipids, 2), 3) and drugs 4) , 5) at the cell and tissue levels. In particular, matrixassisted laser desorption/ionization (MALDI)-MSI and tandem mass spectrometry facilitate the analysis of the distribution and chemical structural information of biomolecules in tissue sections, and they have been applied to pathological 3), 6) and pharmacological 5), 7) studies.
Although there are a variety of applications of MALDI-MSI, much remains to be done to provide high sensitivity and performance in molecular identification. For achieving high sensitivity and e$cient molecular identification, a number of studies on improved tissue-sectioning techniques, 8) a matrix-application method 9), 10) and introduction of quadrupole ion traptime-of-flight (TOF) type instruments 11) have been reported. In addition, the improvement of spatial resolution 12), 13) has been intensively studied. In addition to these topics, we consider that the variation of ionization e$ciency observed among various spectra is another crucial problem of MSI. These variations arise mainly due to heterogeneous matrixanalyte crystallization and sublimation during measurement, which could result in a series of incorrect analyte distribution images. To correct them, we need to process the mass spectra. In fact, in traditional MALDI mass spectrometry (MS), external standards (i.e., exogenous control compounds) were utilized for normalizing the variations in mass spectra.
14)῍16) Because such spectral processing enables highly quantitative analysis by MALDI-MS, we consider that the normalization procedure improves the quantitative aspect of MSI. In this study, we aimed at establishing the normalization procedure in which external standard compounds spiked in the matrix solution are utilized.
Experimental

Sample preparation
This study used a 10-week-old male C57BL/6J mouse. The extirpated brains were immediately frozen in powdered dry ice, and stored at ῌ80῍ until required. All experiments with the mouse were conducted using protocols approved by the Animal Care and Use Committee of the Mitsubishi Kagaku Institute of Life Sciences. Tissue sections were sliced to a thickness of 5 mm 8) using a cryostat (CM3050; Leica, Wetzler, Germany), and were mounted onto indium tin oxide (ITO) glasses (Bruker Daltonics, Leipzig, Germany).
Chemicals
We purchased 1-O-hexadecyl-2-O-(methylcarbamyl)-sn-glycero-3-phosphocholine (methylcarbamyl plateletactivating factor) (C-16) from Cayman Chemical (Ann Arbor, Michigan, USA), and trifluoroacetic acid (TFA) was purchased from Sigma (St. Louis, MO, USA). Meth-anol, sodium acetate, and distilled water were purchased from Nacalai tesque (Kyoto, Japan), and 2,5-dihydroxybenzoic acid (DHB) was purchased from Bruker Daltonics (Leipzig, Germany).
Matrix application
The MALDI matrix used in this study was DHB. The matrix was dissolved in 70῍ methanol, 20 mM sodium acetate, and 0.1῍ TFA at a concentration of 50 mg/mL for DHB. Methylcarbamyl platelet-activating factor (C-PAF) was dissolved in the matrix solutions at concentrations of 0, 0.5, 5, and 50 mg/mL. A thin matrix layer was applied onto the surface using a 0.2-mm nozzle caliber airbrush (Procon Boy FWAPlatinum, Mr. Hobby, Tokyo, Japan). While spraying, a distance of 15 cm between the nozzle and the tissue surface was maintained. After drying, the ITO glass was attached to a MALDI-target plate using a conductive tape to facilitate electrical conduction.
Mass spectrometry
All imaging results presented in this paper were acquired using a MALDI-quadrupole ion trap-TOF mass spectrometer (AXIMA-QIT, Shimadzu, Kyoto, Japan). The acquisition was performed in the low-mass range mode (m/z 300῍1,000) by applying stage voltages of ῌ14 V (positive ion detection). The raster scan on the tissue surface was performed automatically. The interval of data points was 100 mm.
Data conversion and spectrum normalization
In our previous study, we established an imaging system based on a AXIMA-QIT, and introduced the data converter we developed, which is available free of charge.
11) The converted MSI data can be applied to BioMAP, which is a commonly used visualization software. In this study, we used a new version of the converter that equips the spectrum normalization function (Fig. 1, arrow) . This version of the converter can normalize spectra using external standard (ES) compounds (i.e., reference mass peaks) during data conversion. In the case that the intensity of a reference peak is more than a threshold value, spectra are normalized to have equal intensity value of ES peaks. In this study, we performed data conversion and spectrum normalization under the following conditions: conversion m/z range: 560῍860; interval and tolerance: Fig. 1 . Operation screen of the data converter we developed. Directions for use were described previously.
11)
The normalization function was added to this version. N. Hosokawa, Y. Sugiura, and M. Setou ῌ 78 ῌ 0.1 and 0.05, respectively. In addition, the conditions of the data normalization were as follows: peak for normalization: 561.4 (C-PAF) and threshold value: 0.1ῌ. The data converter is freely available for academic use at www.maldi-msi.org, or upon e-mail request (setou@ hama-med.ac.jp).
Results and Discussion
3.1 Characterization of C-PAF as external standard compound in MSI A biological tissue section is a complex mixture of various biomolecules, and their population and concentration could vary among the di#erent parts of the tissue section. Such heterogeneity causes di#erences in analyte ionization e$ciency at di#erent points on the tissue surface. For example, di#erent concentrations of salt perturb the uniform matrix-analyte crystallization on the section. 9) In addition, matrix sublimation occurs during MSI measurements because it takes a few hours in a high-vacuum chamber, resulting in decreasing ionization e$ciency during measurement.
To overcome these problems, we aimed at establishing a data normalization procedure using ES compounds that can eliminate the variations in ionization e$ciency, and thus improve the visualization quality in MSI.
To select a compound that is suitable as an ES, we searched candidate compounds that satisfy the following two criteria: (1) no other mass peaks overlap the peak of the ES compound, and (2) the ES compound has su$cient ionization capability on the tissue section, in which numerous biological compounds compete to ionize. As a candidate, we selected methylcarbamyl platelet-activating factor (C-PAF) (C-16). 17) It has a glycerol backbone and an alkyl group connected by an ether linkage at the C1 carbon to a sixteen-carbon chain. The acyl group at the C2 carbon is modified from an acetate unit to a methyl῍carbamyl unit. The C3 has a phosphocholine head group, just like standard phosphatidylcholine (PC). This artificial compound is a stable analogue of PAF, and is not present in the mouse 
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ῌ 79 ῌ brain. In addition, in the positive ion detection mode, such phospholipids with trimethyl-amine polar-head groups could be easily ionized even on the tissue sections.
3)
Thus, we tested if C-PAF is a suitable compound for ES.
We performed MSI of five successive mouse coronal brain sections treated with a matrix solution containing di#erent concentrations of C-PAF (0, 0.5, 5, 25, and 50 mg/mL), and averaged the mass spectra obtained from the cerebral cortex region of each brain section. Firstly, we confirmed that no mass peak overlapped the peak of C-PAF (m/z 561) (Fig. 2A) . Regarding the second criterion, we found that mass peak of C-PAF was detectable at a concentration of 5 mg/mL in the tissue section, and the peak intensity increased in an exponential manner (Fig. 2B) . Presumably because of ionization competition with other biomolecules, the ion signal of C-PAF weakened in the tissue region ( Figs. 2A  and B) . We also confirmed that other mass peaks were not a#ected by the addition of C-PAF even at the highest concentration (50 mg/mL), in the mass range of 560ῌm/zῌ860 (Fig. 2C) .
3.2 Optimization of C-PAF concentration for spectrum normalization Next, we determined the optimal concentration of C-PAF for spectrum normalization. We converted the acquired mass spectra to ANALYZE 7.5 file format, which is readable by the BioMAP software. The data converter has a spectrum normalization function (Fig.  1) . Using the function, the spectra were normalized so that the C-PAF peaks at m/z 561.4 have equal intensities during the converting process. Figure 3 shows the ion images of C-PAF (m/z 561) with and without spectrum normalization. Regarding the brain section sprayed with the matrix solution containing 0.5, 5, and 25 mg/mL of C-PAF, spectrum normalization could not be performed successfully at some data points because of insu$cient intensity of the ES peak, since mass peaks with insu$cient intensity of C-PAF could not be recognized by the software as ES peaks. On the other hand, successful normalization was achieved for the section sprayed with 50 mg/mL of C-PAF, since ion signals of C-PAF equalized among the data points (Fig. 3A) .
Such normalization produces improved ion images of biomolecules by eliminating the variations in ionization e$ciency. Figure 3B shows the ion images of PC (diacyl-16 : 0/18 : 1) (m/z 782), 2), 18), 19) with and without spectrum normalization. While the inner structure of the brain such as the hippocampus region could not be distinguished in the un-normalized ion images, normalized images (50 mg/mL of C-PAF) showed a clear borderline of the hippocampus, indicated by the absence of PC (diacyl-16 : 0/18 : 1) in the corpus callosum (arrow heads). Figure 4 shows the images of ions corresponding to PC molecular species, with and without normalization. The normalization process with C-PAF clearly improved the ion distribution images, providing sharply defined tissue edges and increased dynamic range.
Conclusions
In this study, we established a normalization procedure in which external standard compounds spiked in the matrix solution are utilized. We evaluated the capability of C-PAF as an ES compound, and then evaluated the optimal concentration of C-PAF as ES. As a result, we found that successful normalization with C-PAF was achieved using a matrix solution with C-PAF at a concentration of 50 mg/mL. By employing this procedure, we also obtained improved ion images of PC molecular species in the mouse brain section. We demonstrated that proper spectrum normalization by ES improves the visualization quality of analyte distribution images by eliminating variations in ionization e$ciency. We consider that the normalization procedure improves the quantitative aspect of MSI for future applications.
